Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis

JN Cornu, P Zantek, G Burtt, C Martin, A Martin… - European urology, 2023 - Elsevier
Context Minimally invasive surgical therapies for male lower urinary tract symptoms
secondary to benign prostatic obstruction were developed to be safer and more tolerable …

The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global …

AF Awedew, H Han, B Abbasi… - The Lancet Healthy …, 2022 - thelancet.com
Background Benign prostatic hyperplasia is a common urological disease affecting older
men worldwide, but comprehensive data about the global, regional, and national burden of …

Heat shock proteins in benign prostatic hyperplasia and prostate cancer

W Ratajczak, M Lubkowski, A Lubkowska - International journal of …, 2022 - mdpi.com
Two out of three diseases of the prostate gland affect aging men worldwide. Benign prostatic
hyperplasia (BPH) is a noncancerous enlargement affecting millions of men. Prostate cancer …

Global burden of benign prostatic hyperplasia in males aged 60–90 years from 1990 to 2019: results from the global burden of disease study 2019

Z Ye, J Wang, Y Xiao, J Luo, L Xu, Z Chen - BMC urology, 2024 - Springer
Background Benign prostatic hyperplasia (BPH) is a prevalent urological disease in elderly
males. However, few studies have estimated the temporal and spatial distributions of the …

Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019

XF Xu, GX Liu, YS Guo, HY Zhu… - American Journal of …, 2021 - journals.sagepub.com
The objective of this study is to provide comprehensive and up-to-date estimates on the
disease burden of BPH in 204 countries and territories between 1990 and 2019. Data about …

Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019

C Zhu, DQ Wang, H Zi, Q Huang, JM Gu, LY Li… - Military Medical …, 2021 - Springer
Background Urinary tract infections (UTI), urolithiasis, and benign prostatic hyperplasia
(BPH) are three of the most common nonmalignant conditions in urology. However, there is …

Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study

D Campobasso, G Siena, P Chiodini, E Conti… - Prostate Cancer and …, 2023 - nature.com
Abstract Background The Rezum system is one of the latest minimally invasive surgical
treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all …

Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study

H Cao, C Shi, Z Aihemaiti, X Dai, F Wang, S Wang - Scientific Reports, 2024 - nature.com
Previous research has suggested that circulating inflammatory proteins are associated with
benign prostatic disease (BPD). This Mendelian randomization (MR) study was conducted to …

Innovative electrochemical electrode modified with Al 2 O 3 nanoparticle decorated MWCNTs for ultra-trace determination of tamsulosin and solifenacin in human …

KAM Attia, AM Abdel-Raoof, A Serag, SM Eid… - RSC …, 2022 - pubs.rsc.org
A simple, cheap, sensitive, and time-saving square wave voltammetric (SWV) procedure
using a carbon paste electrode modified with aluminum oxide nanoparticle decorated multi …

Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study

SY Yue, WY Li, S Xu, XX Bai, WL Xu, X Wang… - Frontiers in …, 2024 - frontiersin.org
Background The gut microbiota has been demonstrated to have a significant role in the
pathogenesis and progression of a variety of diseases, including prostate cancer, prostatitis …